Physician profile
Fred Wolodiger
NPI 1073511085
$907.85
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $140 · 2022: $292 · 2023: $70.20 · 2024: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $339.29 | 2020-2024 | Gattex |
| Tela Bio, INC. | $172.76 | 2022-2024 | Ovitex 2s |
| Kci USA, INC. | $115.15 | 2019 | |
| Integra Lifesciences Corporation | $97.73 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $72.29 | 2019-2023 | Phasix Mesh |
| Polarityte, INC. | $45.23 | 2019 | |
| Ethicon US, LLC | $25.43 | 2023 | Echelon Flex, Stratafix |
| W. L. Gore & Associates, INC. | $21.20 | 2024 | Gore Viabahn Endoprosthesis |
| Shire North American Group INC | $13.77 | 2019 | |
| Intuitive Surgical, INC. | $5.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Wolodiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.